Sino Biopharmaceutical Ltd

01177: XHKG (HKG)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
HK$9.31MxqRjgxzdjv

Sino Biopharmaceutical: Placing Coverage Under Review

We are placing coverage of narrow-moat-rated Sino Biopharmaceutical under review pending the transfer of coverage to a new analyst. We expect to revisit our coverage of this company over the next three months. Our most recent fair value estimate was HKD 6.50.

Sponsor Center